FDA.reportPublic FDA data

vutrisiran 25 MG in 0.5 ML Prefilled Syringe

RxCUI
2604788
RxNorm name
vutrisiran 25 MG in 0.5 ML Prefilled Syringe
Display name
vutrisiran 25 MG in 0.5 ML Prefilled Syringe
Full name
vutrisiran 25 MG in 0.5 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AMVUTTRAVUTRISIRANAlnylam Pharmaceuticals, Inc.8db0facb-81b6-4006-9239-27dc6409c5d32025-11-06Warnings, Adverse reactionsExact identifier
rxcui: 2604788

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8db0facb-81b6-4006-9239-27dc6409c5d3vutrisiran 25 MG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML vutrisiran 50 MG/ML Prefilled Syringe [SCD] · vutrisiran 25 MG (as vutrisiran sodium 26.5 MG) per 0.5 ML Prefilled Syringe [SY]38These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 202220251106